Metformin Plus Gemcitabine Found to Reduce Pancreatic Tumor Burden, Prevent Relapse
Metformin was found to target human pancreatic cancer stem cells in preclinical mouse models.
Diagnosis & Disease Information
Diagnostic Serum Biomarker Panel for Detection of Pancreatic Adenocarcinoma a Possibility
A highly accurate, blood-based diagnostic panel comprising 40 individual serum biomarkers of pancreatic adenocarcinoma would provide high specificity while allowing for heterogeneity among patients and tumor characteristics.
RT with Concurrent Erlotinib, Bevacizumab, Capecitabine Tolerable in Patients with Locally Advanced Pancreatic Cancer
In patients with locally advanced pancreatic cancer, radiotherapy with concurrent erlotinib, bevacizumab, and capecitabine is safe and tolerable, with “promising” overall survival rates and a high rate of resectability at higher dose levels.
High UVR Exposure at Birth Location, Sun-Sensitive Skin Type, and History of Skin Cancer Decrease Pancreatic Cancer Risk
Exposure to high ultraviolet radiation (UVR) at an individual’s birth location confers a lower risk of pancreatic cancer.
Vismodegib Plus Gemcitabine Provide Clinical Benefit in Metastatic Pancreatic Cancer
Sequential delivery of the new targeted therapy vismodegib (GDC-0449; Erivedge) as monotherapy followed by combination treatment with gemcitabine provides clinical benefit to a subset of patients with metastatic pancreatic cancer.
RLIP76 Found to Mediate Pancreatic Cancer Cell Resistance to Chemotherapy and Radiation
The multifunctional cell membrane protein RLIP76 represents a mechanistically significant target for developing effective interventions for pancreatic cancers resistant to chemotherapy and radiation.
Raising Hope for Pancreatic Cancer
Long regarded as the most lethal form of cancer, and a leading cause of death from cancer worldwide, pancreatic cancer remains largely elusive to early detection and warning symptoms.
Pancreatectomy Okay Without Downstaging From Therapy
Radiographic downstaging rare even after neoadjuvant therapy in pancreatic cancer patients.
Novel Agents Fill the Pipeline for Pancreatic Cancer
From chemotherapeutic agents to novel biologicals, there are promising treatment options on the horizon.
Algenpantucel-L Immunotherapy + Standard Therapy Shows Promise in Pancreatic Cancer
Adding algenpantucel-L immunotherapy to standard adjuvant treatment may improve survival in patients undergoing R0/R1 resection for pancreatic cancer.
- Loading...
Loading...
Loading... 
Loading...